Frankfurt - Delayed Quote EUR
Seres Therapeutics, Inc. (1S9.F)
0.0000
0.0000
(0.00%)
At close: April 17 at 4:02:01 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARKOWITZ DAVID A. Chief Financial Officer | Sale | Feb 16, 2024 | 182,442 |
| CLOGHESSY PAULA Officer | Sale | Oct 30, 2023 | 45,684 |
| DESROSIER THOMAS J Officer | Sale | Feb 18, 2025 | 142,456 |
| EGE DAVID S. Chief Technology Officer | Sale | Aug 16, 2024 | 77,575 |
| HENN MATTHEW R Officer | Sale | Feb 18, 2025 | 84,443 |
| SHAFF ERIC D Chief Executive Officer | Sale | Feb 18, 2025 | 192,039 |
| VON MOLTKE LISA Officer | Sale | Feb 18, 2025 | 39,875 |
| YOUNG TERESA L. Officer | Sale | Feb 18, 2025 | 97,536 |
Related Tickers
ADAG Adagene Inc.
1.4800
+2.78%
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
VRDN Viridian Therapeutics, Inc.
13.51
-1.82%
IMCR Immunocore Holdings plc
29.80
+0.95%
GBIO Generation Bio Co.
0.4504
+9.99%
LIPO Lipella Pharmaceuticals Inc.
2.4100
+0.63%
ERAS Erasca, Inc.
1.4200
+2.90%
KYMR Kymera Therapeutics, Inc.
30.70
+6.60%
APM Aptorum Group Limited
0.9601
+6.80%
BCLI Brainstorm Cell Therapeutics Inc.
0.8700
-0.66%